<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336778">
  <stage>Registered</stage>
  <submitdate>7/04/2011</submitdate>
  <approvaldate>13/04/2011</approvaldate>
  <actrnumber>ACTRN12611000387921</actrnumber>
  <trial_identification>
    <studytitle>The role of intravenous iron for patients with anaemia around the time of surgery</studytitle>
    <scientifictitle>The role of intravenous iron compared to standard treatment for patients booked for major abdominal surgery with anaemia around the time of surgery in reduction in allogeneic red cell transfusion".</scientifictitle>
    <utrn>U1111-1120-6310</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Anaemia</healthcondition>
    <healthcondition>Blood</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Haematological diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients randomized to the intervention group will be exposed to intravenenous admistration of Ferric carboxymaltose before (1000mg or max 15mg /kg) and after surgery (50mg per 100ml estimated blood loss)</interventions>
    <comparator>the control group will be managed according to current common practice at the discretion of the surgeon. current practice is correction of moderate to severe anaemia by red cell transfusion and/or on occasion oral iron.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>allogeneic transfusion rate, during hospital stay, pre- and post op, according to medical records</outcome>
      <timepoint>at the time of discharge from the hospital, medical records</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>length of stay according to medical records</outcome>
      <timepoint>at the time of discharge from the hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life, questionnaire SF 36</outcome>
      <timepoint>at 4 weeks post discharge, questionnaire, documentation at surgeon follow up</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Anaemia
Hb,         Ferritin &lt;300 micro g/L
female&lt;120 gram/L, Transferrin Sat &lt;25%
male&lt;130 gram/L</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Other causes of anaemia  haemaglobinopahty, GI bleeding, acute systemic infection, vitamin B12 or folate deficiency, hepatitis, HIV
No consent
Severe asthma
Allergy to iron
Pre-treatment ferritin levels &gt; 300 ng/ml</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>anaemic patients for major abdominal surgery 4-21 days prior to surgery.
Computer random number generator to give you the random sequence and then put this sequence in consecutively numbered opaque sealed envelopes to ensure allocation concelament.</concealment>
    <sequence>Computer random number generator to give you the random sequence and then put this sequence in consecutively numbered opaque sealed envelopes to ensure allocation concelament.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>1/05/2011</anticipatedstartdate>
    <actualstartdate>27/08/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>23/10/2014</actualenddate>
    <samplesize>136</samplesize>
    <actualsamplesize>72</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Lyell McEwin Hospital</primarysponsorname>
    <primarysponsoraddress>Lyell McEwin Hospital
Haydown Rd
Elizabeth Vale SA 5112</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress>none</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>investigators decided to decline the sponsorship offer.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>ETHICS OF HUMAN RESEARCH COMMITTEE (TQEH &amp; LMH)</ethicname>
      <ethicaddress>Executive Officer, Human Research Ethics Committee
 
The Queen Elizabeth Hospital, Lyell McEwin Hospital &amp; Modbury Hospital
Adelaide Health Service
 
Ground Floor, Basil Hetzel Institute for Medical Research, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South SA 5011</ethicaddress>
      <ethicapprovaldate>13/07/2010</ethicapprovaldate>
      <hrec>2009108</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dr Bernd Froessler</name>
      <address>Dept of Anaesthesia
Lyell McEwin Hospital
Haydown Rd
Elizabeth Vale SA 5112</address>
      <phone>+61881829806</phone>
      <fax />
      <email>bernd.froessler@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Bernd Froessler</name>
      <address>Dept of Anaesthesia
Lyell McEwin Hospital
Haydown Rd
Elizabeth Vale SA 5112</address>
      <phone>+61881829806</phone>
      <fax />
      <email>bernd.froessler@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Bernd Froessler</name>
      <address>Dept of Anaesthesia
Lyell McEwin Hospital
Haydown Rd
Elizabeth Vale SA 5112</address>
      <phone />
      <fax />
      <email />
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name> Bernd Froessler</name>
      <address>Dept of Anaesthesia Lyell McEwin Hospital Haydown Rd Elizabeth Vale SA 5112</address>
      <phone>+61881829806</phone>
      <fax />
      <email>bernd.froessler@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>